Skip to main content
. Author manuscript; available in PMC: 2019 Oct 18.
Published in final edited form as: J Card Fail. 2018 Mar 2;24(5):321–329. doi: 10.1016/j.cardfail.2018.02.006

Fig. 3.

Fig. 3.

Distribution of current interventional clinical trials in heart failure according to (A) primary sponsors, (B) primary end points, (C) acuity of heart failure, and (D) therapies. Percentages in panels C and D exceed 100% because of minor overlap in categories. Panel C includes 2 trials that enrolled both chronic stable and acute decompensated heart failure and excludes 11 trials that did not specify the acuity of heart failure. Panel D includes 13 trials that evaluated both medical and surgical therapies, 1 trial that examined both medical and molecular therapies, and 2 trials that considered both surgical and molecular therapies.